Saturday 24 September
Please find below the programme schedule for Saturday 24 September 2022.
Meet the experts session 3
08:00
Suite No. 292 (Ruby) | M3.1 Common errors in clinical mycology
Alessandro C. Pasqualotto, Brazil and O.C. Abraham, India
08:00
Suite No. 293 (Sapphire) | M3.2 Common errors in Medical Mycology laboratory
Nelesh Govender, South Africa and Ariya Chindamporn, Thailand
09:00
Conference hall B | Key note (P8): Challenges in the diagnosis & management of fungal infections in developing countries
Arnaldo Lopes Colombo, Brazil
10:00
Break
Conference hall C - Exhibition
Parallel session 10
Parallel session 10 will take place from 10:30 AM - 12:00 PM and consists of five symposia.
Conference hall B | S10.1 Antifungal dosing in children and adolescents
Chair: Andreas Groll, Germany
10:30
S10.1a Dosing of antifungal agents in NICU
Tanu Singhal, India
10:50
S10.1b Dosing of antifungal agents in the PICU
Fanny Lanternier, France
11:10
S10.1c Dosing of antifungal agents in the cancer and HSCT setting
Andreas Groll, Germany
11:30
S10.1d* Molecular diagnosis and antifungal susceptibility of Colombian clinical isolates of the Sporothrix spp complex
Erika Sánchez Cifuentes, Colombia
11:45
Q&A with all speakers
Conference hall A | S10.2 Fungal Infections in Transplant Patients
Chairs: Xess Immaculata, India and Subramanian Swaminathan, India
10:30
S10.2a Fungal infections in solid organ transplant patients
Parikshit Prayag, India
10:50
S10.2b Fungal infections in bone marrow transplant patients
Subramanian Swaminathan, India
11:10
S10.2c Novel approaches in management of fungal infections in transplant infections
Suneetha Narreddy, India
11:30
S10.2d* Fungal beta-glucans and mannan performances in HIV-associated histoplasmosis
Antoine Adenis, France
11:45
Q&A with all speakers
Suite No. 292 (Ruby) | S10.3 The mycobiome characterization: future perspectives or just a trend?
Chair: Jean-Pierre Gangneux, France
10:30
S10.3a Impact of azole therapy on the microbiome and mycobiome of cystic fibrosis patients
Jean-Pierre Gangneux, France
10:50
10.3b Perspectives and limits of lung mycobiome characterization : where are we in 2021?
Francoise Botterel, France
11:10
S10.3c Clinical studies provide new insights on the association between the microbiota and host resistance to Candida albicans intestinal colonization
Margot Delavy, France
11:30
TBD
11:45
Q&A with all speakers
S10.4 Emerging antifungal resistant fungi
Chairs: Koichi Izumikawa, Japan and Yoshitsugu Miyazaki, Japan
10:30
S10.4a New mechanism & diagnositics of azole resistant aspergillosis
Akira watanabe, China, Japan
10:50
S10.4b Management of chronic pulmonary aspergillosis
Koichi Izumikawa, Japan
11:10
S10.4c Successful treatment of mucormycosis in haematological diseases
Hiroshi Kakeya, Japan
11:30
S10.4d* A unique clinical appearance of Candida auris infection in Japan
Takashi Umeyama, Japan
11:45
Q&A with all speakers
Suite No. 294 (Emerald) | S10.5 Fungal respiratory infections in Cystic Fibrosis
Chairs: Nicolas Papon, France and Benoit Briard, France
10:30
S10.5a TBD
10:50
S10.5b Bacterial-fungal interactions in the CF lung
Benoit Briard, France
11:10
S10.5c Insight into the role of secondary metabolism in the pathogenesis of Scedosporium apiospermum
Nicolas Papon, France
11:30
S10.5d* Disseminated pulmonary infection due to Mortierella wolfii in a 6-year-old patient with X-linked CGD receiving MUD-HSCT
Jung-Ho Youn, USA
11:45
Q&A with all speakers
12:00
Closing ceremony